Correction to "Therapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II - Induced Atherosclerosis, Abdominal Aortic Aneurysms, and Hypertensin".

Abstract

The above article [Alsiraj Y, Thatcher SE, Liang CL, Ali H, Ensor M, and Cassis LA (2021) J Pharmacol Exp Ther, 377:[326–335][1], DOI: <https://doi.org/10.1124/jpet.121.000525>] was accidentally published with the first author’s last name incorrectly listed as AlSiraj. The correct byline for the